Current Development of Biopolymer for Biomedical Applications
A special issue of Polymers (ISSN 2073-4360). This special issue belongs to the section "Biobased and Biodegradable Polymers".
Deadline for manuscript submissions: closed (20 December 2023) | Viewed by 200
Special Issue Editor
Interests: synthesis and activity screening of oligosaccharides; design and synthesis of carbohydrase inhibitors and research on structure–activity relationship; sugar chip technology; sugar nanotechnology; polysaccharide chemistry and polysaccharide biology
Special Issue Information
Dear Colleagues,
Biopolymers are natural polymers produced by organisms; in other words, they are polymeric biomolecules derived from cellular or extracellular substances. According to the monomer units used and the structure of the biopolymers formed, biopolymers are divided into the following three categories: polynucleotides, peptides and polysaccharides. Because one of the main purposes of biomedical engineering is to imitate body parts to maintain normal body function, biopolymers are widely used in tissue engineering, medical equipment and pharmaceutical industries because of their biocompatibility. Many biopolymers can be used in regenerative medicine, tissue engineering, drug delivery and holistic medicine applications because of their mechanical properties. They have the characteristics of wound healing, bioactive catalysis and non-toxicity. Synthetic polymers may show a variety of shortcomings, such as immunogenic rejection and toxicity after degradation. Similar to the human body, many biopolymers usually have better body integration because they also have more complex structures.
Prof. Dr. Gangliang Huang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Polymers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biopolymer
- biomedicine
- regenerative medicine
- tissue engineering
- drug delivery
- holistic medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
